Priority Date: 18.06.10 (EP 20100305655)

AZOLOPYRIDIN-3-ONE DERIVATIVES AS INHIBITORS OF LIPASES AND PHOSPHOLIPASES

  • Application ID: EP11725479
  • Status: The patent has been granted

Applicant

Technology company logo small
Technology Company

Attorneys

no operation time available
1 office
Technology Company
no operation time available
1 office
Technology Company

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). Sanofi-Aventis Deutschland GmbH is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 230 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 18.06.2010 - Priority Date (EP 20100305655)
  • 22.12.2011 - Publication A1 (WO2011157827)
  • 24.04.2013 - Publication A1 (EP2582709)
  • 24.01.2018 - Publication B1 (EP2582709)

IPC Classification